10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2020 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 18, 2021) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
Revenues | |||
Premiums | $ 104,109 | 94,173 | 85,421 |
Product Revenue | 10,384 | 2,760 | 0 |
Administrative fees and other revenue | 6,315 | 6,208 | 5,920 |
Total operating revenue | 120,808 | 103,141 | 91,341 |
Net investment income | 877 | 1,005 | 970 |
Net realized gains (losses) on financial instruments | 182 | 67 | (206) |
Total revenues | 121,867 | 104,213 | 92,105 |
Expenses | |||
Benefit expense | 88,045 | 81,786 | 71,895 |
Cost of products sold | 8,953 | 1,992 | 0 |
Selling, general and administrative expense | 17,450 | 13,364 | 14,020 |
Interest expense | 784 | 746 | 753 |
Amortization of other intangible assets | 361 | 338 | 358 |
Loss on extinguishment of debt | 36 | 2 | 11 |
Total expenses | 115,629 | 98,228 | 87,037 |
Income before income tax expense | 6,238 | 5,985 | 5,068 |
Income tax expense | 1,666 | 1,178 | 1,318 |
Net income | 4,572 | 4,807 | 3,750 |
Net income per share | |||
Basic net income per share | 18.23 | 18.81 | 14.53 |
Diluted net income per share | 17.98 | 18.47 | 14.19 |
Dividends per share | 3.80 | 3.20 | 3.00 |
External Links | |
ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2020 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |